John Wilkinson

John brings over 30 years of experience from both pharmaceutical and research settings in Australia and the United Kingdom, with a focus on the development of small molecules to target viruses and cancer. John graduated from the University of Portsmouth (BSc Hons) in 1988 and has a PhD in HIV-1 Immunovirology from the University of NSW. His research interests include Drug Development, Virology, Oncology and Immunology, translating novel laboratory findings into human clinical trials that have previously resulted in numerous peer-reviewed publications. Prior to joining Noxopharm, John was the Chief Scientific Officer at Biotron Limited, where he was responsible for the oversight of Biotron's antiviral programs and instrumental in the HIV-1 clinical programs. At Noxopharm, John will manage the scientific, research and technological operations of the company, help set company research and scientific priorities that align with the company's mission and vision.